Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Synthetic Form of IL-2, an Important Active Immunotherapy Drug, Produced with Fewer Adverse Effects

Synthetic Form of IL-2, an Important Active Immunotherapy Drug, Produced with Fewer Adverse Effects

What Is Interleukin 2 (IL-2)?

Interleukin 2 is naturally present in the body and important in activating the immune system . Because of IL-2’s immune-stimulating properties, it has been externally administered for cancer and autoimmune diseases as immunotherapy since the 1990s (first approved in 1992, high-dose IL-2 treatment for advanced kidney cancer). However, IL-2’s substantial toxicity limits clinical use. In January 2019, Nature published a study designing synthetic IL-2 with lower toxicity and all natural IL-2 functions. Synthetic IL-2 can effectively activate cancer-fighting T cells .

types of cancer immunotherapy cellular immunotherapy

Stage 4. malignant melanoma skin cancer and kidney cancer patients achieved, with high-dose IL-2, up to 9 percent complete response . However, high-dose IL-2 has potentially serious effects, greatly limiting its clinical use.

IL-2 binds to cell-surface receptors to control two immune cell types. IL-2’s effects depend on receptor interactions. Natural IL-2 activates cells with beta and gamma receptors, producing anticancer immunity. But natural IL-2 also activates alpha-receptor-bearing cells, causing severe toxicity and immune suppression. To design IL-2 without adverse effects, researchers used the Rosetta computer program. They obtained a protein binding IL-2 receptor beta but not IL-2 receptor alpha. Research took place at the University of Washington Institute for Protein Design in the United States. The synthetic IL-2 protein was called Neo-2/15 . It also has, besides IL-2, the functions of another anticancer immunotherapy molecule, IL-15. In laboratory and animal models, Neo-2/15 bound only cells with beta and gamma receptors, activated T cells, and caused no adverse effects.

What does this study mean for us?

  • It may enable protein-based treatments for cancer and autoimmune diseases.
  • After 30 years of research failing to make IL-2 safe and effective, this study provides a new approach.
  • Although highly effective, IL-2 has not been used ideally in clinics because of serious adverse effects. This study may offer hope to many cancer patients.

Sources

Daniel-Adriano Silva, Shawn Yu, Umut Y. Ulge ve ark.
De novo design of potent and selective mimics of IL-2 and IL-15.
Nature, 09 January 2019.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Synthetic Form of IL-2, an Important Active Immunotherapy Drug, Produced with Fewer Adverse Effects

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy